CVM 2012 Annual Report Appendix A
The Office of the Center Director directs overall Center activities and coordinates and establishes Center-wide policy. The Center Director serves as CVM’s primary representative and spokesperson concerning our activities, interacting with the general public, industry, other government agencies, and national and international organizations.
The Office of Management is responsible for the day-to-day management and operations of CVM. More importantly, the Office of Management carries out its tasks through careful attention to its responsibility as a participating steward of the organization as a whole, specializing in administrative and technical problem solving and advocating the CVM mission's needs.
The Office of Minor Use and Minor Species reports directly to the CVM Director and is responsible for overseeing incentives for the development of new animal drugs for minor species and minor uses in major species.
The Office of New Animal Drug Evaluation administers the core function of drug review, which involves directing the approval process of animal drugs. CVM evaluates drugs intended to benefit the health and productivity of food animals and the health of companion animals. CVM also has drug regulatory authority over articles (other than food) that affect the structure or any function of an animal’s body.
The Office of Surveillance and Compliance has primary responsibility for three of CVM’s four core functions: compliance-related actions, post-approval monitoring, and animal feed safety. The Office of Surveillance and Compliance monitors the safety and effectiveness of approved drugs after they enter the market, coordinates enforcement actions against unapproved drugs that are on the market and that threaten public and animal health.
The Office of Research is the laboratory-based research arm of CVM. Scientists at the Office of Research conduct applied research in support of regulatory decision-making related to each of CVM’s core functions